Anwar, Yumna
Bansal, Kanika
Kucukosmanoglu, Murat
Dang, Quang
Feltch, Cody
Brooks, Justin
Banerjee, Nilanjan
Funding for this research was provided by:
National Institutes of Health (1R43MH133495-01A1)
Article History
Received: 24 June 2025
Accepted: 25 February 2026
First Online: 12 March 2026
Declarations
:
: JB, CF, and NB are shareholders of Tanzen Medical Inc., the company that developed the RestEaze TM device evaluated in this study. All other authors declare that they have no competing interests.